Silver Oak Securities
AZN icon

Silver Oak Securities’s AstraZeneca AZN Stock Holding History

Silver Oak Securities’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$207K Buy
+1,112
New +$185K 0.02% 777

Other funds holding AZN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return
SEB Asset Management
SEB Asset Management Stockholm $27B AUM
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Silver Oak Securities's AZN Position: Q3 2026 in Review

Silver Oak Securities opened a new position in AstraZeneca (AZN) in Q3 2026: 1,112 shares worth $207K. The stake represents 0.02% of the portfolio and ranks #777 among its holdings.

918 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Silver Oak Securities held 1,112 shares of AstraZeneca worth $207K as of Q3 2026.
  • AstraZeneca was a new Silver Oak Securities position in Q3 2026.
  • AstraZeneca made up 0.02% of Silver Oak Securities's portfolio in Q3 2026, its #777 holding.
  • 918 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Silver Oak Securities's 13F filing for Q3 2026, filed 9 Nov 2026.